Transfection of ovarian cancer cells with tumor necrosis factor-alpha (TNF-alpha) antisense mRNA abolishes the proliferative response to interleukin-1 (IL-1) but not TNF-alpha

Gynecol Oncol. 1994 Apr;53(1):59-63. doi: 10.1006/gyno.1994.1088.

Abstract

Recombinant interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) can induce endogenous TNF-alpha mRNA expression and stimulate proliferation of epithelial ovarian cancer cells. In a previous report, proliferation induced by either cytokine could be partially blocked by soluble TNF-alpha receptor or by neutralizing antibodies against TNF-alpha. In the present study, we have transfected the ovarian cancer cell line OVCA 432 with vectors that contain the TNF-alpha gene in the antisense or sense orientation. Antisense-transfected cells showed a 4.5- to 26-fold reduction in IL-1-induced TNF-alpha secretion. Similarly, the stimulation of [3H]thymidine incorporation by IL-1 but not by TNF-alpha was blocked by TNF-alpha antisense transfection. These results are consistent with a model in which the macrophage-derived cytokines IL-1 and TNF-alpha might stimulate endogenous production of TNF-alpha that in turn could stimulate proliferation of ovarian cancer cells by autocrine growth regulation.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Division / drug effects
  • Cell Division / physiology
  • Female
  • Humans
  • Interleukin-1 / pharmacology*
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / pathology*
  • RNA, Antisense / genetics*
  • RNA, Antisense / pharmacology*
  • RNA, Messenger / genetics*
  • RNA, Messenger / pharmacology*
  • Stimulation, Chemical
  • Transfection
  • Tumor Cells, Cultured / drug effects
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tumor Necrosis Factor-alpha / genetics*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Interleukin-1
  • RNA, Antisense
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha